AI for Onsite Cytology Evaluation in Endoscopic Ultrasound
Artificial Intelligence for Onsite Cytology Evaluation in Endoscopic Ultrasound
Orlando Health, Inc.
200 participants
Nov 12, 2025
OBSERVATIONAL
Conditions
Summary
The aim of this study is to determine if the widely available artificial intelligence platform ChatGPT can accurately identify the abnormalities present on cytology specimens obtained at EUS-FNB of solid mass lesions in the gastrointestinal tract, in comparison with interpretation by cytopathologists as the gold standard.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
EUS-guided fine needle biopsy of solid mass lesions in the gastrointestinal tract
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07228689